Should We Routinely Screen for Warfarin Gene Polymorphism in Patients with Coumadin Overdose?
Genetic polymorphisms can affect an individual's response to the pharmacological agents. Warfarin has a narrow therapeutic range and dose arrangement may vary from individual to individual. An insufficient dose may fail to prevent thromboembolism and overdose may increase the risk of bleeding....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2016-12-01
|
| Series: | Eurasian Journal of Emergency Medicine |
| Subjects: | |
| Online Access: |
http://akademikaciltip.com/archives/archive-detail/article-preview/should-we-routinely-screen-for-warfarin-gene-polym/21808
|